Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2025

I know that one day I will be cured, and all will be well: Perspectives on acceptability of curative therapies for sickle cell disease in Tanzania.

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDaima BukiniKKKassim KassimCKCollins Kanza

Discussion

Loading...

Member takes

Overview

Qualitative study reveals factors affecting acceptability of curative therapies for sickle cell disease in Tanzania, suggesting strategies for implementation.

Key Points

  • Patients and caregivers showed significant interest in curative therapies for sickle cell disease.
  • Factors influencing therapy acceptance included financial costs and caregiving burdens.
  • Tailored engagement strategies are necessary for patients under 18, as most sickle cell patients in Africa are children.
  • Healthcare professionals require knowledge to adequately address patient and caregiver concerns about treatments.

Cite This Study

Bukini et al. (2025) studied this question.

synapsesocial.com/papers/689a0c65e6551bb0af8cf8c8https://doi.org/10.1101/2025.07.31.25332489
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1“I know that one day I will be cured”: Perspectives on acceptability of curative therapies for sickle cell disease in Tanzania2026
  2. 2Combining deliberative engagement with qualitative research to assess patient and caregiver perspectives on curative therapies for sickle cell disease in Africa2025
  3. 3Out of Reach: Understanding Resource Barriers to Gene Therapy for Pediatric Patients With Sickle Cell Disease2026
  4. 4Systematic review of economic evaluations of curative treatments for sickle cell disease2026
  5. 5Gene based therapy for sickle cell disease in low and middle income countries insights from the Gambia2026